Status:
COMPLETED
Trial of Montelukast for Treatment of Acute Bronchiolitis
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Bronchiolitis
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
The primary rationale for this study is to evaluate the effect of once daily montelukast on duration of acute illness in infants with first-time bronchiolitis.
Eligibility Criteria
Inclusion
- Male or female infants aged 3 to 12 months of age
- Diagnosis by emergency physician of bronchiolitis
Exclusion
- Any previous episode, as determined by a physician, of wheezing, bronchiolitis or asthma
- Any history of previous bronchodilator use prior to this illness
- Treatment with corticosteroids in the 14 days prior to the current illness
- Immunosuppression
- Immunodeficiency
- Caregiver does not speak English
- Diagnosis by the treating ED physician of croup
- Diagnosis by the treating ED physician of pneumonia
- Caregiver does not have access to a telephone
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT00863317
Start Date
December 1 2008
End Date
July 1 2011
Last Update
July 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States, 53226